Reversal of proarrhythmic effects of flecainide acetate and encainide hydrochloride by propranolol.

Circulation
R J MyerburgA Castellanos

Abstract

The use of membrane-active antiarrhythmic agents may be complicated by aggravation of existing arrhythmias or development of new drug-induced arrhythmias. Four patients, referred because of out-of-hospital cardiac arrest or symptomatic sustained ventricular tachycardia, were receiving class IC antiarrhythmic agents in an attempt to prevent inducibility of sustained ventricular tachycardia. New or worsening spontaneous arrhythmias developed while they were on flecainide acetate (n = 3) or encainide hydrochloride (n = 1) therapy. Spontaneous runs of rapid nonsustained and sustained ventricular tachycardia developed in two. Increased frequency of premature ventricular contractions and repetitive forms of ventricular ectopic activity developed in one, despite the fact that inducibility of sustained ventricular tachycardia had been prevented. Salvos and nonsustained ventricular tachycardia developed in the fourth patient. Propranolol had failed to prevent inducibility of sustained ventricular tachycardia during previous programmed stimulation studies in three of the four patients, but it reproducibly suppressed drug-induced arrhythmias that appeared only after administration of the IC agents in each patient. Suppression of the proar...Continue Reading

References

Apr 30, 1987·The American Journal of Cardiology·D P Zipes
Apr 30, 1987·The American Journal of Cardiology·P J PodridB Lown
Jul 15, 1989·Annals of Internal Medicine·M E Josephson
Apr 30, 1987·The American Journal of Cardiology·J Morganroth
Apr 30, 1987·The American Journal of Cardiology·J T Bigger, D I Sahar
Dec 1, 1984·The American Journal of Cardiology·R J MyerburgA Castellanos
Nov 24, 1983·The New England Journal of Medicine·J N RuskinE Kelly
Feb 27, 1984·The American Journal of Cardiology·G P Lewis, J L Holtzman
Feb 27, 1984·The American Journal of Cardiology·J Morganroth, L N Horowitz

❮ Previous
Next ❯

Citations

Jul 1, 1990·Clinical Cardiology·D Katritsis, A J Camm
Nov 1, 1991·Journal of Clinical Pharmacology·N Z Kerin
Feb 1, 1991·Journal of Clinical Pharmacology·E M Vaughan Williams
Aug 10, 2002·Current Cardiology Reports·Michael J Reiter
Nov 11, 1998·The American Journal of Cardiology·A O Grant
Nov 11, 1998·The American Journal of Cardiology·P L Friedman, W G Stevenson
Jun 12, 2003·Journal of the American College of Cardiology·William G Stevenson, Kyoko Soejima
Oct 31, 2000·Critical Care Medicine·G M Chaudhry, C I Haffajee
Nov 1, 1990·Pacing and Clinical Electrophysiology : PACE·A O Grant
Oct 1, 1992·Pacing and Clinical Electrophysiology : PACE·J NazariR F Kehoe
Jul 1, 1996·Pacing and Clinical Electrophysiology : PACE·A C WiesfeldK I Lie
Nov 1, 1994·Journal of Cardiovascular Electrophysiology·R H Falk, R I Fogel
Oct 1, 1995·Journal of Cardiovascular Electrophysiology·R A FilartP R Kowey
Apr 21, 1999·Journal of Cardiovascular Electrophysiology·R J MyerburgA Castellanos
Jun 1, 1992·Postgraduate Medical Journal·M Dancy
Aug 1, 1992·The Journal of Clinical Investigation·M J BarberA O Grant
Apr 17, 2002·Circulation Journal : Official Journal of the Japanese Circulation Society·Yoshiki Nagata
Nov 4, 2016·Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology·Alessandro CapucciFederico Guerra
Jan 6, 2001·Drug Safety : an International Journal of Medical Toxicology and Drug Experience·T C Trujillo, P E Nolan
Oct 1, 1994·The American Journal of Cardiology·H L KennedyS Goldstein
Dec 1, 1990·The American Journal of Cardiology·D G KaralisE L Michelson
Oct 15, 1992·The American Journal of Cardiology·F LombardiE Cappiello
Apr 26, 2006·The American Journal of Emergency Medicine·Miguel A AriasJosé L Merino
Feb 1, 1997·Current Problems in Cardiology·S ViskinJ E Olgin
Sep 16, 1998·The American Journal of Cardiology·M J Reiter, J A Reiffel
Sep 16, 1998·The American Journal of Cardiology·P T Sager
Sep 16, 1998·The American Journal of Cardiology·D M Roden
Sep 1, 1994·American Heart Journal·N Z Kerin, J Somberg
Oct 23, 2012·Journal of the American College of Cardiology·Demosthenes G KatritsisA John Camm
Nov 20, 2016·Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology·Demosthenes G KatritsisJack Rickard
Feb 14, 2018·Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology·Gheorghe-Andrei DanUNKNOWN ESC Scientific Document Group
Sep 12, 2000·Current Cardiology Reports·P J Podrid
Apr 30, 2003·Journal of Cardiovascular Pharmacology·Philip B AdamsonPeter J Schwartz
Apr 21, 1999·Journal of Cardiovascular Electrophysiology·J E Olgin, S Viskin
Feb 1, 1993·Circulation·S C Krishnan, C Antzelevitch

❮ Previous
Next ❯

Related Concepts

Related Feeds

Arrhythmia

Arrhythmias are abnormalities in heart rhythms, which can be either too fast or too slow. They can result from abnormalities of the initiation of an impulse or impulse conduction or a combination of both. Here is the latest research on arrhythmias.

Anti-Arrhythmic Drug Therapies

Anti-arrhythmic drugs are used to prevent abnormal heart rhythms. These medications are used in conditions including, ventricular tachycardia, ventricular fibrillation and atrial fibrillation. Discover the latest research on anti-arrhythmic drug therapies here.

Atrial Fibrillation

Atrial fibrillation is a common arrhythmia that is associated with substantial morbidity and mortality, particularly due to stroke and thromboembolism. Here is the latest research.

Cardiology Journals

Discover the latest cardiology research in this collection of the top cardiology journals.

Antiarrhythmic Agents: Mechanisms of Action

Understanding the mechanism of action of antiarrhythmic agents is essential in developing new medications as treatment of cardiac arrhythmias is currently limited by the reduced availability of safe and effective drugs. Discover the latest research on Antiarrhythmic Agents: Mechanism of Action here.